EBS Emergent Biosolutions Inc

$EBS well, totals are in — 2.3 million shares were traded. This is twice the avg daily volume. Significant buying pressure.

$EBS it’s the beginning of the end… or the beginning of the beginning for EBS… See you at 15++

$EBS Significant drop in short borrowing rates, indicating a lower demand to short. Inventory is back up to 1.7M shares. The company cash on hand as of Sep 30 is expected to be $200M (by me). Plenty of ammo for a surprise note buyback.

$EBS Let's see. This year we've had: hanta, ebola, plague. These are all indications for which there is no commercial pre-exposure prophylaxis, so only Uncle Sam can generate demand. Uncle Sam just handed $280M to Regeneron for Inmazeb, is again financing CEPI, it set up its own Ebola vaccine program, and funding for ASPR remains unchanged for over 3 years (inflation is eating it). I think the Trump administration has hit the limit of hard power, and governance realities in the health file, and is removing the choke. Feels like there's more air to breathe here now.

$EBS Canton restart is being "inaugurated" today, with 50 jobs slated to be filled. Pretty sure Substipharm is paying for that. Which begs the question, where are the cuts from the fourth round of restructuring coming from?

$EBS Covered all my shorts at $4.75 and bought back 50K shares on Thursday at $5.52. I have a strong feeling something significant is going to happen here within the next six months. I'm positioned and ready.

$EBS Took profit a bit over $1.00 to buy $RARE @ $12.80 (golden opportunity after the gap down) and $ALVO around $5.00-5.15 (FDA decision coming soon). Hope Papa can turn the company around and help push the stock back up to $12 for y’all within 6 months. Wishing you all the best!

$EBS you have to go long here because after hours is the time to create panic for tomorrow

$EBS OOHHHHH BABY WE RISING !!!!! Bio defense play - RUSSIA PLAGUE HAPPENING NOW 💰💰💰💰💰💰💰💰💰 CHECK THE NEWS !!!!!

$EBS Contract awards are in bound....good timing with the Russia plague news fueling the momentum!!... See you at 15++.. Might even hit 20 by year-end!

$EBS click bait trying to get interest fir a failing business by including ai… sad I was stuck here for so long leave now feel liberated

$EBS Is EBS finally going to get it's credit rating upgrade or is there a large contract award... or could we get both!!! ....see you at 10++

$EBS Folks the Russia news is just heating up.. we maintained $7 today after a rocket of a day yesterday. EOW PT $10.00 Lessssgoooooooo 💰💰💰💰💰💰💰💰 💸💸💸💸💸💸💸💸 🇷🇺🇷🇺🇷🇺🇷🇺🇷🇺🇷🇺🇷🇺🇷🇺

$EBS I clearly got the CYFENDUS successor contract renewal wrong. This stock kills me. Hopefully the awareness that we still live in a dangerous world is getting more attention.

$EBS lol showing a lot of strength during first 30 mins of the trading day bodes well for the rest of the day. long day coming for the shorty, lol

Emergent BioSolutions shares rose sharply as a suspected pneumonic plague death at Russia’s Irkutsk Anti-Plague Research Institute in Siberia fueled demand for biodefense stocks. U.S. Secretary of State Marco Rubio and the State Department are monitoring the incident and coordinating with the CDC and other agencies, while urging Moscow to provide accurate and timely information. Russian authorities officially attributed the death to pneumonia of unknown etiology and denied a laboratory accident, but local officials activated containment measures, placing at least 197 potential contacts under medical observation or quarantine. The development is particularly relevant to Emergent given its portfolio of approved medical countermeasures. The rally was also supported by strong recent results. $EBS

$EBS Price: $6.95 Volume: Above average Catalyst: Recent chikungunya/smallpox vaccine supply updates and biodefense contract news are driving renewed trader interest. Resistance: $7.50 Support: $6.30 Bull case: A close above $7.50 on strong volume could spark a momentum run toward the next supply zone. Bear case: Failure to hold $6.30 support may trigger a retest of recent lows near $5.80. What I'm watching: Watching for a volume-confirmed breakout above resistance or a breakdown below support to gauge next direction. Note: I’m not a financial advisor or a market predictor, and I don’t offer any premium subscriptions or paid services.